- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02377050
Randomized Controlled Trial of Higher-Volume Feedings in Preterm Neonates
June 14, 2018 updated by: Colm Travers, University of Alabama at Birmingham
The primary hypothesis is that preterm infants who are less than or equal to 32 weeks gestation and weigh 1001-2500 grams at birth will have an increase in weight gain with a feeding goal of 180-200 ml/kg/day more than the commonly used feeding goal of 140-160 ml/kg/day
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The proposed trial is designed to test the primary hypothesis that in preterm infants weighing 1001-2500 grams at birth and who are less than or equal to 32 weeks gestation, feeding goals of 180-200 ml/kg/day will increase weight gain (g/k/day) from time of enrollment to discharge home or 36 weeks post-menstrual age (PMA)(whichever comes first) more than the commonly used feeding goal volume of 140-160 ml/kg/day (usual feeding goal).
This is a pilot study to determine the safety of increased volumes of feedings as opposed to fortification of feedings.
Study Type
Interventional
Enrollment (Actual)
224
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35249
- University of Alabama at Birmingham
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 day to 1 month (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Inborn or outborn infants born at a gestational age of 32 weeks or less; Birthweight 1001-2500; Feeding volume of at least 120 ml/kg/day; Enrolled prior to 28 days of age and prior to exceeding 32 weeks
Exclusion Criteria:
- Hemodynamically significant patent ductus arteriosis; History of necrotizing enterocolitis Bell Stage II or greater; Known gastrointestinal or neurologic malformations; Prior or planned enrollment into the NICHD MILK Trial; Terminal illness or decision to withhold or limit support
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Higher Volume Feeding Goal
Infants randomized to this group will have higher volume feeding goals of 180-200 ml/kg/day.
|
feeding volume goal of 180-200 ml/kg/day
|
No Intervention: Usual Volume Feeding Goal
Infants randomized to this group will have feeding goals of 140-160 ml/kg/day.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Weight gain
Time Frame: baseline to average 12 weeks of age
|
Average change in weight between baseline and 12 weeks
|
baseline to average 12 weeks of age
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mid arm circumference
Time Frame: baseline to average 12 weeks of age
|
average change in mid arm circumference between baseline and 12 weeks
|
baseline to average 12 weeks of age
|
Length
Time Frame: baseline to average 12 weeks of age
|
average change in length between baseline and 12 weeks
|
baseline to average 12 weeks of age
|
Head circumference
Time Frame: baseline to average 12 weeks of age
|
average change in head circumference between baseline and 12 weeks
|
baseline to average 12 weeks of age
|
Caloric intake
Time Frame: 36 weeks
|
Average difference in weekly caloric intake between groups
|
36 weeks
|
Length of stay
Time Frame: 36 weeks or discharge
|
Days from study entry to discharge home
|
36 weeks or discharge
|
Rates of infants less than 10th percentile for weight
Time Frame: 36 weeks or discharge
|
Rates of infants less than 10th percentile for weight at study completion
|
36 weeks or discharge
|
Change in weight z score
Time Frame: 36 weeks or discharge
|
Change in weight z score from study entry to completion
|
36 weeks or discharge
|
Change in length z score
Time Frame: 36 weeks or discharge
|
Change in length z score from study entry to completion
|
36 weeks or discharge
|
Change in head circumference z score
Time Frame: 36 weeks or discharge
|
Change in head circumference z score from study entry to completion
|
36 weeks or discharge
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Body fat composition
Time Frame: 36 weeks or discharge
|
Percentage of body fat composition
|
36 weeks or discharge
|
Rates of necrotizing enterocolitis (Bell Stage ≥ 2)
Time Frame: 36 weeks or discharge
|
Safety outcome: Rates of necrotizing enterocolitis (Bell Stage ≥ 2)
|
36 weeks or discharge
|
Rates of feeding intolerance
Time Frame: 36 weeks or discharge
|
Safety outcome: Rates of feeding intolerance defined as withholding feeds for > 24 hours due to gastrointestinal cause after study entry
|
36 weeks or discharge
|
Rates of culture proven sepsis
Time Frame: 36 weeks or discharge
|
Safety outcome: Rates of blood culture positive sepsis after study entry
|
36 weeks or discharge
|
Duration of respiratory support
Time Frame: 36 weeks or discharge
|
Safety outcome: Duration of respiratory support (oxygen, continuous positive airway pressure/high flow nasal cannula/mechanical ventilation) after study entry
|
36 weeks or discharge
|
Rates of bronchopulmonary dysplasia
Time Frame: 36 weeks or discharge
|
Safety outcome: Rates of bronchopulmonary dysplasia
|
36 weeks or discharge
|
Rates of moderate to large or symptomatic patent ductus arteriosus
Time Frame: 36 weeks or discharge
|
Safety outcome: Rates of moderate to large or symptomatic patent ductus arteriosus after study entry
|
36 weeks or discharge
|
Rates of adverse safety outcomes combined
Time Frame: 36 weeks or discharge
|
Safety outcome: Safety outcome: Rates of bronchopulmonary dysplasia, necrotizing enterocolitis ≥ stage 2, feeding intolerance, culture proven sepsis, patent ductus arteriosus after study entry
|
36 weeks or discharge
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Colm Travers, MD, University of Alabama at Birmingham
- Ariel A Salas, MD, University of Alabama at Birmingham
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Salas AA, Travers CP, Jerome ML, Chandler-Laney P, Carlo WA. Percent Body Fat Content Measured by Plethysmography in Infants Randomized to High- or Usual-Volume Feeding after Very Preterm Birth. J Pediatr. 2021 Mar;230:251-254.e3. doi: 10.1016/j.jpeds.2020.11.028. Epub 2020 Nov 25.
- Travers CP, Wang T, Salas AA, Schofield E, Dills M, Laney D, Yee A, Bhatia A, Winter L, Ambalavanan N, Carlo WA. Higher- or Usual-Volume Feedings in Infants Born Very Preterm: A Randomized Clinical Trial. J Pediatr. 2020 Sep;224:66-71.e1. doi: 10.1016/j.jpeds.2020.05.033. Epub 2020 May 25.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2015
Primary Completion (Actual)
June 1, 2018
Study Completion (Actual)
June 1, 2018
Study Registration Dates
First Submitted
December 1, 2014
First Submitted That Met QC Criteria
February 24, 2015
First Posted (Estimate)
March 3, 2015
Study Record Updates
Last Update Posted (Actual)
June 18, 2018
Last Update Submitted That Met QC Criteria
June 14, 2018
Last Verified
June 1, 2018
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- UAB NEO 013
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infant Premature
-
University of MiamiPontificia Universidad Catolica de ChileTerminated
-
Johnson & Johnson Pharmaceutical Research & Development...TerminatedInfant, Premature | Infant, Newborn
-
NICHD Neonatal Research NetworkNational Center for Research Resources (NCRR)CompletedSepsis | Infant, Small for Gestational Age | Infant, Premature | Infant, Low Birth Weight | Infant, NewbornUnited States
-
Aydin Adnan Menderes UniversityCompletedNursing Caries | Infant Development | Premature Infant Disease | Patient ComfortTurkey
-
University of VirginiaRecruitingDevelopment, Infant | Premature Infant DiseaseUnited States
-
Universidad de LeónCompletedPremature Birth | Premature Infant | Massage | Preterm Infant
-
Istituto Giannina GasliniEubrainRecruiting
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaCompletedPreterm Birth | Cerebral Autoregulation | Premature Infant DiseaseItaly
-
Sun Yat-sen UniversityRecruitingPremature Infant DiseaseChina
-
Instituto Nacional de Perinatologia Isidro Espinosa...UnknownImmune System Diseases | Premature Infant Disease | Immunoglobulin DeficiencyMexico
Clinical Trials on Higher Volume Feeding Goal
-
Taichung Veterans General HospitalUnknown
-
Peking UniversityRecruitingGrowth RetardationChina
-
NICHD Neonatal Research NetworkEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedRetinopathy of Prematurity | Bronchopulmonary Dysplasia (BPD) | Infant, Small for Gestational Age | Infant, Premature | Infant, Low Birth Weight | Infant, NewbornUnited States
-
Universidade Federal do Triangulo MineiroUnknownPostmenopause | Breast Cancer SurvivorsBrazil
-
CSL BehringCompletedHereditary Angioedema Types I and IIUnited States, Spain, Australia, Canada, Czechia, Hungary, Israel, Italy, Romania, United Kingdom
-
University Health Network, TorontoCompleted
-
Atatürk UniversityRecruiting
-
University Hospital Schleswig-HolsteinCompletedPostoperative Complications | Hemodynamic Instability | Ultrasound ImagingGermany
-
Yonsei UniversityUnknownBile Duct Cancer | Pancreas Cancer | Ampulla of Vater CancerKorea, Republic of
-
Rigshospitalet, DenmarkUnknownHead and Neck CancerDenmark